My Locations
Part of the Duke Cancer Institute
About Me
I became a doctor to serve patients. The dedication, drive, and enthusiasm to be a compassionate doctor are traits I learned as a former professional athlete and I continuously apply those qualities to my journey as a doctor. My primary clinical interests are cancer patients particularly the surgical care of patients with melanoma, skin cancers, soft tissue cancers and other general surgical oncology. My favorite part of being a surgeon who specializes in cancer is that each patient is truly unique and there are no routines; this allows for a personal approach in which plans are made together with the patient. Finally, I believe that Duke is a place where success and achievements in patient care are the direct result of highly productive teams that include highly talented students, residents, nurses, support staff, and physicians.
- Associate Professor of Surgery, Surgical Oncology 2024
- Associate Professor in Medicine, Medicine, Medical Oncology 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute 2017
Areas of Expertise
- Melanoma
- Lymph Node Dissection
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Clinical Focus and Research
I am dedicated to advancing the care of cancer patients through research. My primary research interests are utilizing novel treatments for melanoma through appropriately designed clinical trials. In collaboration with basic scientists, we are also working to understand interactions of the immune system with cancer and how the immune system might be manipulated to fight cancer. I also enjoy clinical research whereby patient data is reviewed to answer important questions.
-
Melanoma BiorepositoryIRB# PRO00100644
-
Replimune (Melanoma and Other Skin Cancers)IRB# PRO00106412 , NCT# NCT03767348
-
Neoadjuvant Daromun + Surgery (Melanoma)IRB# PRO00110577 , NCT# NCT03567889
- Duke Research Training Program in Surgical Oncology awarded by National Institutes of Health 2024 - 2029
- Beasley, Georgia M., and John A. Olson. What's new in neoadjuvant therapy for breast cancer? Vol. 44, 2010. https://doi.org/10.1016/j.yasu.2010.05.013.
- DeVito, Nicholas C., Y-Van Nguyen, Michael Sturdivant, Michael P. Plebanek, Kaylee A. Villarreal, Nagendra Yarla, Vaibhav Jain, et al. “GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling.” Cancer Res 85, no. 9 (May 2, 2025): 1644–62. https://doi.org/10.1158/0008-5472.CAN-24-1130.
- Beckhorn, Catherine B., Kristen E. Rhodin, Harold J. Leraas, Norma E. Farrow, Jay S. Lee, Georgia M. Beasley, and Elisabeth T. Tracy. “National Trends in Management of the Nodal Basin for Pediatric Patients With Occult Stage III Melanoma in the United States.” Pediatr Blood Cancer 72, no. 5 (May 2025): e31627. https://doi.org/10.1002/pbc.31627.
- Zager, Jonathan S., Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J. Eschelman, Evan S. Glazer, Aslam Ejaz, et al. “An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.” Ann Surg Oncol, April 7, 2025. https://doi.org/10.1245/s10434-025-17231-x.
- Beasley, G. M., H. M. Kroon, M. I. Ross, P. C. A. Kam, J. F. Thompson, and D. S. Tyler. “Isolated limb infusion for melanoma.” In Cutaneous Melanoma, Fifth Edition, 541–60, 2024. https://doi.org/10.1201/9781315140711-31.
- Rhodin, K. E., K. Baecher, W. T. Mehtsun, M. Lowe, G. Boland, and G. M. Beasley. “The Role of Surgery in Managing Primary and Metastatic Melanoma.” In Cancer Metastasis Through the Lymphovascular System, 385–94, 2022. https://doi.org/10.1007/978-3-030-93084-4_36.
- Farrow, N. E., A. Therien, D. S. Tyler, and G. M. Beasley. “Melanoma.” In Genomic and Precision Medicine: Oncology, Third Edition, 319–31, 2022. https://doi.org/10.1016/B978-0-12-800684-9.00005-8.
- Montgomery, Kelsey B., M Chandler McLeod, Danielle K. DePalo, Michelle M. Dugan, Jonathan S. Zager, Kelly M. Elleson, Michael S. Sabel, et al. “Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort.” In Ann Surg Oncol, 32:1453–62, 2025. https://doi.org/10.1245/s10434-024-16498-w.
- Robert, C., M. M. Milhem, J. J. Sacco, J. Michels, G. K. In, E. Muñoz-Couselo, D. Schadendorf, et al. “LBA46 Primary efficacy, safety, and survival data from the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE clinical trial with RP1 combined with nivolumab.” In Annals of Oncology, 35:S1236–37. Elsevier BV, 2024. https://doi.org/10.1016/j.annonc.2024.08.2287.
- Rhodin, Kristen E., Shayna Hollander, Douglas Tyler, Georgia M. Beasley, Smita Nair, and Matthew K. Iyer. “Whole Transcriptome Profiling of Patients with In Transit Melanoma.” In ANNALS OF SURGICAL ONCOLOGY, 31:S65–S65, 2024.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.